Functional Neuroimaging of Treatment Effects in Psychiatry: Methodological Challenges and Recommendations

被引:15
作者
Dichter, Gabriel S. [1 ,2 ,3 ]
Sikich, Linmarie [1 ,2 ]
Song, Allen [3 ]
Voyvodic, James [3 ]
Bodfish, James W. [1 ,2 ]
机构
[1] Univ N Carolina, Chapel Hill Sch Med, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Psychiat, Chapel Hill Sch Med, Chapel Hill, NC 27599 USA
[3] Duke Univ, Med Ctr, Duke UNC Brain Imaging & Anal Ctr, Durham, NC USA
关键词
clinical trials; fMRI; functional magnetic resonance imaging; neurodevelopmental disorders; psychiatry; TEST-RETEST RELIABILITY; NORMAL BRAIN-DEVELOPMENT; WORKING-MEMORY; CLINICAL-TRIALS; BLOOD-FLOW; NIH MRI; COGNITIVE NEUROSCIENCE; PLACEBO TREATMENTS; FMRI; CHILDREN;
D O I
10.3109/00207454.2012.678446
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Functional magnetic resonance imaging (fMRI) has helped to elucidate the neurobiological bases of psychiatric and neurodevelopmental disorders by localizing etiologically-relevant aberrations in brain function. Functional MRI also has shown great promise to help understand potential mechanisms of action of effective treatments for a range of psychiatric and neurodevelopmental disorders, including mood and anxiety disorders, schizophrenia, and autism. However, the use of fMRI to probe intervention effects in psychiatry is associated with unique methodological considerations, including the psychometric properties of repeated fMRI scans, how to assess potential relations between the effects of an intervention on symptoms and on specific brain activation patterns, and how to best make causal inferences about intervention effects on brain function. Additionally, the study of treatment effects in neurodevelopmental disorders presents additional unique challenges related to brain maturation, analysis methods, and the potential for motion artifacts. We review these methodological considerations and provide recommendations for best practices for each of these topics.
引用
收藏
页码:483 / 493
页数:11
相关论文
共 94 条
[1]   The NIH MRI study of normal brain development (Objective-2): Newborns, infants, toddlers, and preschoolers [J].
Almli, C. R. ;
Rivkin, M. J. ;
McKinstry, R. C. .
NEUROIMAGE, 2007, 35 (01) :308-325
[2]  
[Anonymous], J VIS EXP
[3]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[4]   Long-term test-retest reliability of functional MRI in a classification learning task [J].
Aron, AR ;
Gluck, MA ;
Poldrack, RA .
NEUROIMAGE, 2006, 29 (03) :1000-1006
[5]   Instructional treatment associated with changes in brain activation in children with dyslexia [J].
Aylward, EH ;
Richards, TL ;
Berninger, VW ;
Nagy, WE ;
Field, KM ;
Grimme, AC ;
Richards, AL ;
Thomson, JB ;
Cramer, SC .
NEUROLOGY, 2003, 61 (02) :212-219
[6]   Using Brain Imaging Measures in Studies of Procognitive Pharmacologic Agents in Schizophrenia: Psychometric and Quality Assurance Considerations [J].
Barch, Deanna M. ;
Mathalon, Daniel H. .
BIOLOGICAL PSYCHIATRY, 2011, 70 (01) :13-18
[7]   Selecting Paradigms From Cognitive Neuroscience for Translation into Use in Clinical Trials: Proceedings of the Third CNTRICS Meeting [J].
Barch, Deanna M. ;
Carter, Cameron S. ;
Arnsten, Amy ;
Buchanan, Robert W. ;
Cohen, Jonathan D. ;
Geyer, Mark ;
Green, Michael F. ;
Krystal, John H. ;
Nuechterlein, Keith ;
Robbins, Trevor ;
Silverstein, Steven ;
Smith, Edward E. ;
Strauss, Milton ;
Wykes, Til ;
Heinssen, Robert .
SCHIZOPHRENIA BULLETIN, 2009, 35 (01) :109-114
[8]   Improving the Prediction of Response to Therapy in Autism [J].
Bent, Stephen ;
Hendren, Robert L. .
NEUROTHERAPEUTICS, 2010, 7 (03) :232-240
[9]  
Bookheimer SY, 2000, MENT RETARD DEV D R, V6, P161, DOI 10.1002/1098-2779(2000)6:3<161::AID-MRDD2>3.3.CO
[10]  
2-N